Structure

Physi-Chem Properties

Molecular Weight:  286.23
Volume:  335.608
LogP:  6.779
LogD:  5.084
LogS:  -6.028
# Rotatable Bonds:  4
TPSA:  20.23
# H-Bond Aceptor:  1
# H-Bond Donor:  1
# Rings:  2
# Heavy Atoms:  1

MedChem Properties

QED Drug-Likeness Score:  0.666
Synthetic Accessibility Score:  3.79
Fsp3:  0.6
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.729
MDCK Permeability:  1.213459745486034e-05
Pgp-inhibitor:  0.863
Pgp-substrate:  0.01
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.999
30% Bioavailability (F30%):  0.997

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.446
Plasma Protein Binding (PPB):  98.99038696289062%
Volume Distribution (VD):  8.113
Pgp-substrate:  3.655839443206787%

ADMET: Metabolism

CYP1A2-inhibitor:  0.883
CYP1A2-substrate:  0.921
CYP2C19-inhibitor:  0.779
CYP2C19-substrate:  0.862
CYP2C9-inhibitor:  0.691
CYP2C9-substrate:  0.937
CYP2D6-inhibitor:  0.642
CYP2D6-substrate:  0.872
CYP3A4-inhibitor:  0.777
CYP3A4-substrate:  0.523

ADMET: Excretion

Clearance (CL):  14.837
Half-life (T1/2):  0.097

ADMET: Toxicity

hERG Blockers:  0.092
Human Hepatotoxicity (H-HT):  0.763
Drug-inuced Liver Injury (DILI):  0.489
AMES Toxicity:  0.234
Rat Oral Acute Toxicity:  0.15
Maximum Recommended Daily Dose:  0.952
Skin Sensitization:  0.809
Carcinogencity:  0.162
Eye Corrosion:  0.144
Eye Irritation:  0.969
Respiratory Toxicity:  0.569

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC151477

Natural Product ID:  NPC151477
Common Name*:   7-Hydroxyerogorgiaene
IUPAC Name:   (5R,8S)-3,8-dimethyl-5-[(2S)-6-methylhept-5-en-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol
Synonyms:   7-Hydroxyerogorgiaene
Standard InCHIKey:  HWRNTAPYVJUXEL-YQQAZPJKSA-N
Standard InCHI:  InChI=1S/C20H30O/c1-13(2)7-6-8-14(3)17-10-9-15(4)18-12-20(21)16(5)11-19(17)18/h7,11-12,14-15,17,21H,6,8-10H2,1-5H3/t14-,15-,17+/m0/s1
SMILES:  CC(=CCC[C@H](C)[C@H]1CC[C@H](C)c2cc(c(C)cc12)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL477696
PubChem CID:   3001918
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0000351] Biflorane and serrulatane diterpenoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO31261 Pseudopterogorgia elisabethae Species Gorgoniidae Eukaryota n.a. West Indian sea n.a. PMID[10425124]
NPO31261 Pseudopterogorgia elisabethae Species Gorgoniidae Eukaryota n.a. n.a. n.a. PMID[10822593]
NPO31261 Pseudopterogorgia elisabethae Species Gorgoniidae Eukaryota n.a. West Indian sea n.a. PMID[11170678]
NPO31261 Pseudopterogorgia elisabethae Species Gorgoniidae Eukaryota n.a. n.a. n.a. PMID[12828474]
NPO31261 Pseudopterogorgia elisabethae Species Gorgoniidae Eukaryota n.a. Colombian n.a. PMID[15497938]
NPO31261 Pseudopterogorgia elisabethae Species Gorgoniidae Eukaryota n.a. n.a. n.a. PMID[17715964]
NPO31261 Pseudopterogorgia elisabethae Species Gorgoniidae Eukaryota n.a. n.a. n.a. PMID[21978379]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT88 Organism Mycobacterium tuberculosis Mycobacterium tuberculosis Activity = 77.0 % PMID[516378]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC151477 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9798 High Similarity NPC117115
0.97 High Similarity NPC21594
0.9612 High Similarity NPC260323
0.9612 High Similarity NPC176279
0.9608 High Similarity NPC58865
0.9519 High Similarity NPC250323
0.9429 High Similarity NPC715
0.9423 High Similarity NPC151537
0.934 High Similarity NPC195922
0.9333 High Similarity NPC46940
0.9327 High Similarity NPC141782
0.9327 High Similarity NPC132720
0.9327 High Similarity NPC13482
0.9252 High Similarity NPC192948
0.9252 High Similarity NPC35797
0.9238 High Similarity NPC95716
0.9167 High Similarity NPC38893
0.9167 High Similarity NPC471668
0.9167 High Similarity NPC308311
0.9167 High Similarity NPC477137
0.9151 High Similarity NPC471179
0.9135 High Similarity NPC11554
0.9118 High Similarity NPC238696
0.9083 High Similarity NPC304510
0.9083 High Similarity NPC477136
0.9083 High Similarity NPC172219
0.9048 High Similarity NPC314187
0.901 High Similarity NPC211885
0.9 High Similarity NPC6597
0.9 High Similarity NPC79241
0.9 High Similarity NPC471671
0.9 High Similarity NPC77492
0.8991 High Similarity NPC219112
0.8981 High Similarity NPC268160
0.8942 High Similarity NPC271274
0.8932 High Similarity NPC272029
0.8919 High Similarity NPC93071
0.8919 High Similarity NPC469644
0.8919 High Similarity NPC151197
0.8919 High Similarity NPC126002
0.89 High Similarity NPC259512
0.89 High Similarity NPC312132
0.8899 High Similarity NPC147179
0.8889 High Similarity NPC317869
0.8889 High Similarity NPC322239
0.8889 High Similarity NPC263753
0.8879 High Similarity NPC469912
0.8879 High Similarity NPC322753
0.8846 High Similarity NPC138942
0.8839 High Similarity NPC478121
0.8835 High Similarity NPC168829
0.8829 High Similarity NPC154030
0.8824 High Similarity NPC72729
0.8824 High Similarity NPC225506
0.8818 High Similarity NPC469663
0.8818 High Similarity NPC308828
0.8818 High Similarity NPC92
0.8807 High Similarity NPC107240
0.88 High Similarity NPC8392
0.8796 High Similarity NPC228425
0.8785 High Similarity NPC224870
0.8785 High Similarity NPC296683
0.8761 High Similarity NPC32322
0.8761 High Similarity NPC241001
0.8761 High Similarity NPC259703
0.875 High Similarity NPC288411
0.8739 High Similarity NPC299180
0.8739 High Similarity NPC16030
0.8738 High Similarity NPC252105
0.8727 High Similarity NPC469719
0.8725 High Similarity NPC252821
0.8725 High Similarity NPC122005
0.8725 High Similarity NPC299762
0.8725 High Similarity NPC33675
0.8716 High Similarity NPC117846
0.8704 High Similarity NPC77772
0.8704 High Similarity NPC266937
0.8704 High Similarity NPC470770
0.87 High Similarity NPC245187
0.8684 High Similarity NPC249340
0.8684 High Similarity NPC154696
0.8684 High Similarity NPC162935
0.8679 High Similarity NPC320439
0.8661 High Similarity NPC469609
0.8627 High Similarity NPC32674
0.8627 High Similarity NPC156313
0.8624 High Similarity NPC177962
0.8624 High Similarity NPC62867
0.8624 High Similarity NPC302371
0.8614 High Similarity NPC144682
0.8614 High Similarity NPC222146
0.8609 High Similarity NPC121168
0.8609 High Similarity NPC297057
0.8609 High Similarity NPC11250
0.8596 High Similarity NPC129176
0.8585 High Similarity NPC54765
0.8571 High Similarity NPC475225
0.8559 High Similarity NPC246760
0.8559 High Similarity NPC84999
0.8558 High Similarity NPC51015
0.8558 High Similarity NPC477685
0.8545 High Similarity NPC321589
0.8534 High Similarity NPC471187
0.8532 High Similarity NPC470723
0.8532 High Similarity NPC165770
0.8532 High Similarity NPC4493
0.8532 High Similarity NPC224527
0.8532 High Similarity NPC225679
0.8532 High Similarity NPC476632
0.8529 High Similarity NPC216520
0.8529 High Similarity NPC132271
0.8529 High Similarity NPC292730
0.8529 High Similarity NPC473388
0.8529 High Similarity NPC82664
0.8519 High Similarity NPC186385
0.8519 High Similarity NPC299568
0.8515 High Similarity NPC76938
0.8509 High Similarity NPC260832
0.8509 High Similarity NPC135467
0.85 High Similarity NPC204210
0.85 High Similarity NPC231150
0.85 High Similarity NPC304541
0.8496 Intermediate Similarity NPC206
0.8491 Intermediate Similarity NPC47284
0.8491 Intermediate Similarity NPC219286
0.8491 Intermediate Similarity NPC99557
0.8485 Intermediate Similarity NPC70436
0.8482 Intermediate Similarity NPC115808
0.8482 Intermediate Similarity NPC154511
0.8482 Intermediate Similarity NPC474358
0.8482 Intermediate Similarity NPC474387
0.8482 Intermediate Similarity NPC247858
0.8482 Intermediate Similarity NPC141001
0.8482 Intermediate Similarity NPC137496
0.8482 Intermediate Similarity NPC257540
0.8476 Intermediate Similarity NPC235762
0.8476 Intermediate Similarity NPC471228
0.8476 Intermediate Similarity NPC108497
0.8476 Intermediate Similarity NPC269212
0.8468 Intermediate Similarity NPC471534
0.8468 Intermediate Similarity NPC249270
0.8462 Intermediate Similarity NPC199273
0.8462 Intermediate Similarity NPC181334
0.8455 Intermediate Similarity NPC43525
0.8455 Intermediate Similarity NPC166995
0.8448 Intermediate Similarity NPC71094
0.8448 Intermediate Similarity NPC176208
0.8447 Intermediate Similarity NPC225464
0.8431 Intermediate Similarity NPC32714
0.8431 Intermediate Similarity NPC274678
0.8431 Intermediate Similarity NPC26244
0.8426 Intermediate Similarity NPC95344
0.8426 Intermediate Similarity NPC64586
0.8426 Intermediate Similarity NPC262365
0.8421 Intermediate Similarity NPC176893
0.8416 Intermediate Similarity NPC3358
0.8416 Intermediate Similarity NPC306884
0.8416 Intermediate Similarity NPC94139
0.8416 Intermediate Similarity NPC210497
0.8416 Intermediate Similarity NPC147284
0.8416 Intermediate Similarity NPC162314
0.8411 Intermediate Similarity NPC469913
0.8411 Intermediate Similarity NPC53740
0.8407 Intermediate Similarity NPC470760
0.84 Intermediate Similarity NPC192
0.8396 Intermediate Similarity NPC254965
0.8396 Intermediate Similarity NPC327811
0.8396 Intermediate Similarity NPC475580
0.8393 Intermediate Similarity NPC474486
0.839 Intermediate Similarity NPC137750
0.839 Intermediate Similarity NPC124030
0.8384 Intermediate Similarity NPC19680
0.8381 Intermediate Similarity NPC12221
0.8378 Intermediate Similarity NPC23804
0.8365 Intermediate Similarity NPC128723
0.8365 Intermediate Similarity NPC92730
0.8362 Intermediate Similarity NPC474115
0.8362 Intermediate Similarity NPC253627
0.835 Intermediate Similarity NPC202986
0.8349 Intermediate Similarity NPC254833
0.8349 Intermediate Similarity NPC19808
0.8349 Intermediate Similarity NPC33728
0.8349 Intermediate Similarity NPC228343
0.8348 Intermediate Similarity NPC103916
0.8333 Intermediate Similarity NPC66834
0.8333 Intermediate Similarity NPC128062
0.8333 Intermediate Similarity NPC48342
0.8333 Intermediate Similarity NPC152415
0.8333 Intermediate Similarity NPC164649
0.8333 Intermediate Similarity NPC289769
0.8333 Intermediate Similarity NPC27323
0.8333 Intermediate Similarity NPC151715
0.8333 Intermediate Similarity NPC328694
0.8333 Intermediate Similarity NPC316301
0.8319 Intermediate Similarity NPC100414
0.8319 Intermediate Similarity NPC312105
0.8319 Intermediate Similarity NPC261973
0.8319 Intermediate Similarity NPC325294
0.8319 Intermediate Similarity NPC43000
0.8319 Intermediate Similarity NPC321822

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC151477 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8972 High Similarity NPD7635 Approved
0.89 High Similarity NPD288 Approved
0.8857 High Similarity NPD2342 Discontinued
0.88 High Similarity NPD844 Approved
0.8725 High Similarity NPD3020 Approved
0.8614 High Similarity NPD1809 Phase 2
0.86 High Similarity NPD845 Approved
0.8519 High Similarity NPD4750 Phase 3
0.8431 Intermediate Similarity NPD2860 Approved
0.8431 Intermediate Similarity NPD2859 Approved
0.8349 Intermediate Similarity NPD3021 Approved
0.8349 Intermediate Similarity NPD3022 Approved
0.8333 Intermediate Similarity NPD3091 Approved
0.8333 Intermediate Similarity NPD2934 Approved
0.8333 Intermediate Similarity NPD2933 Approved
0.8333 Intermediate Similarity NPD1432 Clinical (unspecified phase)
0.822 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.819 Intermediate Similarity NPD3019 Approved
0.819 Intermediate Similarity NPD2932 Approved
0.819 Intermediate Similarity NPD4059 Approved
0.8113 Intermediate Similarity NPD289 Clinical (unspecified phase)
0.8103 Intermediate Similarity NPD4093 Discontinued
0.8051 Intermediate Similarity NPD3092 Approved
0.8034 Intermediate Similarity NPD4626 Approved
0.8034 Intermediate Similarity NPD1751 Approved
0.8034 Intermediate Similarity NPD2286 Discontinued
0.8018 Intermediate Similarity NPD1792 Phase 2
0.8 Intermediate Similarity NPD7325 Clinical (unspecified phase)
0.7881 Intermediate Similarity NPD3095 Discontinued
0.787 Intermediate Similarity NPD846 Approved
0.787 Intermediate Similarity NPD940 Approved
0.7863 Intermediate Similarity NPD5304 Approved
0.7863 Intermediate Similarity NPD5303 Approved
0.7826 Intermediate Similarity NPD497 Approved
0.78 Intermediate Similarity NPD111 Approved
0.7798 Intermediate Similarity NPD5700 Clinical (unspecified phase)
0.7787 Intermediate Similarity NPD3094 Phase 2
0.7748 Intermediate Similarity NPD1445 Approved
0.7748 Intermediate Similarity NPD1444 Approved
0.7739 Intermediate Similarity NPD498 Approved
0.7739 Intermediate Similarity NPD2234 Approved
0.7739 Intermediate Similarity NPD495 Approved
0.7739 Intermediate Similarity NPD496 Approved
0.7739 Intermediate Similarity NPD2228 Approved
0.7739 Intermediate Similarity NPD2229 Approved
0.7731 Intermediate Similarity NPD4589 Approved
0.7724 Intermediate Similarity NPD2194 Approved
0.7724 Intermediate Similarity NPD2195 Approved
0.7719 Intermediate Similarity NPD6124 Clinical (unspecified phase)
0.7712 Intermediate Similarity NPD2226 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD7340 Approved
0.768 Intermediate Similarity NPD4625 Phase 3
0.7661 Intermediate Similarity NPD3635 Approved
0.7661 Intermediate Similarity NPD3636 Approved
0.7661 Intermediate Similarity NPD5736 Approved
0.7661 Intermediate Similarity NPD3637 Approved
0.7656 Intermediate Similarity NPD4097 Suspended
0.7647 Intermediate Similarity NPD5691 Approved
0.7638 Intermediate Similarity NPD4060 Phase 1
0.7615 Intermediate Similarity NPD1242 Phase 1
0.76 Intermediate Similarity NPD2605 Approved
0.76 Intermediate Similarity NPD2606 Approved
0.7586 Intermediate Similarity NPD7159 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD1398 Phase 1
0.7561 Intermediate Similarity NPD6696 Suspended
0.7561 Intermediate Similarity NPD1283 Approved
0.754 Intermediate Similarity NPD5156 Approved
0.754 Intermediate Similarity NPD5155 Approved
0.7521 Intermediate Similarity NPD3026 Approved
0.7521 Intermediate Similarity NPD3023 Approved
0.75 Intermediate Similarity NPD3025 Approved
0.75 Intermediate Similarity NPD1651 Approved
0.75 Intermediate Similarity NPD3024 Approved
0.748 Intermediate Similarity NPD4749 Approved
0.7477 Intermediate Similarity NPD9500 Approved
0.746 Intermediate Similarity NPD3594 Approved
0.746 Intermediate Similarity NPD3595 Approved
0.7459 Intermediate Similarity NPD1201 Approved
0.7458 Intermediate Similarity NPD6671 Approved
0.744 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.744 Intermediate Similarity NPD4624 Approved
0.7422 Intermediate Similarity NPD6663 Approved
0.7364 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7364 Intermediate Similarity NPD3620 Phase 2
0.736 Intermediate Similarity NPD4339 Clinical (unspecified phase)
0.7317 Intermediate Similarity NPD1281 Approved
0.7297 Intermediate Similarity NPD3028 Approved
0.7288 Intermediate Similarity NPD5283 Phase 1
0.7288 Intermediate Similarity NPD4869 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD7330 Discontinued
0.7258 Intermediate Similarity NPD2233 Approved
0.7258 Intermediate Similarity NPD2230 Approved
0.7258 Intermediate Similarity NPD2232 Approved
0.7244 Intermediate Similarity NPD2861 Phase 2
0.7222 Intermediate Similarity NPD1470 Approved
0.7218 Intermediate Similarity NPD5408 Approved
0.7218 Intermediate Similarity NPD5404 Approved
0.7218 Intermediate Similarity NPD5405 Approved
0.7218 Intermediate Similarity NPD5406 Approved
0.7213 Intermediate Similarity NPD4235 Clinical (unspecified phase)
0.7213 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD1669 Approved
0.72 Intermediate Similarity NPD5327 Phase 3
0.7197 Intermediate Similarity NPD7718 Clinical (unspecified phase)
0.7177 Intermediate Similarity NPD5350 Clinical (unspecified phase)
0.7177 Intermediate Similarity NPD5351 Clinical (unspecified phase)
0.7177 Intermediate Similarity NPD1611 Approved
0.7167 Intermediate Similarity NPD709 Approved
0.7143 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7743 Approved
0.7143 Intermediate Similarity NPD7742 Approved
0.7119 Intermediate Similarity NPD228 Approved
0.7107 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD9610 Approved
0.7105 Intermediate Similarity NPD9608 Approved
0.7101 Intermediate Similarity NPD7390 Discontinued
0.7099 Intermediate Similarity NPD4140 Approved
0.7097 Intermediate Similarity NPD1983 Approved
0.7097 Intermediate Similarity NPD2688 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD1981 Approved
0.7097 Intermediate Similarity NPD3143 Discontinued
0.7097 Intermediate Similarity NPD1980 Approved
0.7083 Intermediate Similarity NPD1793 Approved
0.7083 Intermediate Similarity NPD1791 Approved
0.7083 Intermediate Similarity NPD1476 Clinical (unspecified phase)
0.7077 Intermediate Similarity NPD2028 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7054 Intermediate Similarity NPD4908 Phase 1
0.705 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD5735 Approved
0.704 Intermediate Similarity NPD1610 Phase 2
0.7037 Intermediate Similarity NPD4721 Approved
0.7037 Intermediate Similarity NPD4726 Approved
0.7037 Intermediate Similarity NPD4725 Approved
0.7016 Intermediate Similarity NPD5238 Clinical (unspecified phase)
0.7016 Intermediate Similarity NPD2667 Approved
0.7016 Intermediate Similarity NPD2668 Approved
0.7007 Intermediate Similarity NPD7003 Approved
0.6992 Remote Similarity NPD2157 Approved
0.6992 Remote Similarity NPD6353 Approved
0.6985 Remote Similarity NPD4256 Phase 2
0.6985 Remote Similarity NPD4257 Approved
0.6984 Remote Similarity NPD3070 Discontinued
0.6978 Remote Similarity NPD2421 Approved
0.6978 Remote Similarity NPD2420 Approved
0.6978 Remote Similarity NPD7040 Clinical (unspecified phase)
0.6978 Remote Similarity NPD7041 Phase 2
0.697 Remote Similarity NPD2979 Phase 3
0.6967 Remote Similarity NPD7636 Approved
0.6963 Remote Similarity NPD6099 Approved
0.6963 Remote Similarity NPD6100 Approved
0.6953 Remote Similarity NPD1164 Approved
0.6947 Remote Similarity NPD6812 Clinical (unspecified phase)
0.6934 Remote Similarity NPD2211 Approved
0.6934 Remote Similarity NPD2209 Approved
0.6934 Remote Similarity NPD3638 Discontinued
0.6917 Remote Similarity NPD9379 Approved
0.6917 Remote Similarity NPD9377 Approved
0.6911 Remote Similarity NPD7644 Approved
0.6899 Remote Similarity NPD6584 Phase 3
0.6885 Remote Similarity NPD6387 Discontinued
0.6879 Remote Similarity NPD6090 Discontinued
0.6866 Remote Similarity NPD4579 Clinical (unspecified phase)
0.6864 Remote Similarity NPD2684 Approved
0.6861 Remote Similarity NPD7037 Approved
0.6846 Remote Similarity NPD4208 Discontinued
0.6842 Remote Similarity NPD1616 Discontinued
0.6842 Remote Similarity NPD2238 Phase 2
0.6838 Remote Similarity NPD2935 Discontinued
0.6835 Remote Similarity NPD7910 Clinical (unspecified phase)
0.6822 Remote Similarity NPD3055 Approved
0.6822 Remote Similarity NPD3053 Approved
0.6814 Remote Similarity NPD9273 Approved
0.6812 Remote Similarity NPD6674 Discontinued
0.6807 Remote Similarity NPD5451 Approved
0.6803 Remote Similarity NPD475 Phase 2
0.6803 Remote Similarity NPD5951 Approved
0.68 Remote Similarity NPD3443 Approved
0.68 Remote Similarity NPD3445 Approved
0.68 Remote Similarity NPD3444 Approved
0.6797 Remote Similarity NPD4659 Approved
0.6788 Remote Similarity NPD5762 Approved
0.6788 Remote Similarity NPD5763 Approved
0.6788 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6783 Remote Similarity NPD4817 Approved
0.6783 Remote Similarity NPD4818 Approved
0.6777 Remote Similarity NPD1138 Approved
0.6767 Remote Similarity NPD6407 Approved
0.6767 Remote Similarity NPD8032 Phase 2
0.6767 Remote Similarity NPD6405 Approved
0.6765 Remote Similarity NPD4108 Discontinued
0.6763 Remote Similarity NPD8166 Discontinued
0.6748 Remote Similarity NPD7157 Approved
0.6744 Remote Similarity NPD5310 Approved
0.6744 Remote Similarity NPD5311 Approved
0.6742 Remote Similarity NPD3027 Phase 3
0.672 Remote Similarity NPD1548 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data